Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shalini Nath
Observed name:
SHALINI NATH
Institutions:
Jaipuria Institute of Management,
Weill Cornell Medicine
Observed institutions:
NewYork–Presbyterian Hospital,
Indian Institute of Chemical Biology,
Jaipuria Institute of Management,
Weill Cornell Medicine,
Weill Cornell Medical Center,
Council of Scientific and Industrial Research
show all 6
ORCID:
0000-0003-1914-6416
Observed ORCID:
0000-0003-1914-6416
OpenAlex ID:
A5063017830
Influence of single and binary doping of strontium and lithium on in vivo biological properties of bioactive glass scaffolds
2016
·
Pintu Kumar Khan
, Arnab Mahato
, et al.
·
Scientific Reports
·
69
PDF
Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells
2018
·
Shalini Nath
, Chhabinath Mandal
, et al.
·
Cell Death and Disease
·
60
PDF
Desialylation of Atg5 by sialidase (Neu2) enhances autophagosome formation to induce anchorage-dependent cell death in ovarian cancer cells
2021
·
Eswara Murali Satyavarapu
, Shalini Nath
, et al.
·
Cell Death Discovery
·
29
PDF
Desialylation of Sonic-Hedgehog by Neu2 Inhibits Its Association with Patched1 Reducing Stemness-Like Properties in Pancreatic Cancer Sphere-forming Cells
2020
·
Shalini Nath
, Susmita Mondal
, et al.
·
Cells
·
16
PDF
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer
2025
·
Sally E. Claridge
, Shalini Nath
, et al.
·
Clinical and Translational Medicine
·
3
PDF
Placing purines in precision medicine: Targeting a metabolic reliance in KRAS-mutant tumors
2026
·
Lamberto De Boni
, Sally Claridge
, et al.
·
iScience
·
2
Wired to Win, Drained to Play: Investigating the Personality‐Fatigue Nexus in Gamers
2026
·
Rehan Husain
, Shalini Nath
·
Journal of Consumer Behaviour
·
1
Unlocking the therapeutic potential of rigosertib as a selective therapy for ovarian cancer
2025
·
Shalini Nath
, Sally Claridge
, et al.
·
Cell Reports Medicine
·
1
Correction: Association of cytosolic sialidase Neu2 with plasma membrane enhances Fas-mediated apoptosis by impairing PI3K-Akt/mTOR-mediated pathway in pancreatic cancer cells
2022
·
Shalini Nath
, Chhabinath Mandal
, et al.
·
Cell Death and Disease
·
1
PDF
A novel preclinical platform to study FGFR2 fusion-driven cholangiocarcinoma☆
2026
·
Alexandra Wolf
, Matias Facciuto
, et al.
·
JHEP Reports
PDF
17A novel immuno-oncology preclinical pipeline to study FGFR2 fusion-driven cholangiocarcinoma
2026
·
Alexandra Wolf
, Emily R Bramel
, et al.
·
The Oncologist
Organoid-T cell co-cultures functionally stratify tumor-reactive T cells and their responses to immune checkpoint inhibitors
2026
·
Elliot Merritt
, Julie-ann Cavallo-fleming
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 6001: Unlocking therapeutic potential of rigosertib as a selective therapy for ovarian cancer
2025
·
Shalini Nath
, Sally Claridge
, et al.
·
Cancer Research
Abstract A015: Unlocking therapeutic potential of rigosertib as a selective therapy for ovarian cancer
2025
·
SHALINI NATH
, Sally Claridge
, et al.
·
Cancer Research
Show more works
View as search
Works count:
14
Citation count:
182
H-index:
4
I10-index:
4
Year
Topic
Type